Patents by Inventor Jan Lindhardt Petersen

Jan Lindhardt Petersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Electronically assisted drug delivery device
    Patent number: 9186465
    Abstract: The present invention relates to electronically assisted drug delivery devices (100). The drug delivery device may include a Gray code type detector for sensing dosage data, wherein the detector comprises a code track consisting of a sequence of alternating markings and a plurality of detectors that are mutually spaced in a direction extending along the code track. The drug delivery device may also include a dosage selector (260) which is moved in a proximal direction upon dose setting and in a distal direction upon dose injection, where the dosage selector is latched in the end of dose position by a latching element, the latching element actuating an end of dose switch for signalling the end of dose state. The drug delivery device may also incorporate power-management arrangements which effectively minimizes power consumption for the incorporated electronic circuitry.
    Type: Grant
    Filed: November 5, 2009
    Date of Patent: November 17, 2015
    Assignee: Novo Nordisk A/S
    Inventors: Bjarke Dupont Jørgensen, Jan Lindhardt Petersen, Steven Linnebjerg, Henrik Groth Ludvigsen, Michael Ejstrup Hansen, Erik Beyerholm, Ramin Nateghi Elahi
  • ELECTRONICALLY ASSISTED DRUG DELIVERY DEVICE
    Publication number: 20110270214
    Abstract: The present invention relates to electronically assisted drug delivery devices (100). The drug delivery device may include a Gray code type detector for sensing dosage data, wherein the detector comprises a code track consisting of a sequence of alternating markings and a plurality of detectors that are mutually spaced in a direction extending along the code track. The drug delivery device may also include a dosage selector (260) which is moved in a proximal direction upon dose setting and in a distal direction upon dose injection, where the dosage selector is latched in the end of dose position by a latching element, the latching element actuating an end of dose switch for signalling the end of dose state. The drug delivery device may also incorporate power-management arrangements which effectively minimizes power consumption for the incorporated electronic circuitry.
    Type: Application
    Filed: November 5, 2009
    Publication date: November 3, 2011
    Applicant: Novo Nordisk A/S
    Inventors: Bjarke Dupont Jørgensen, Jan Lindhardt Petersen, Steven Linnebjerg, Henrik Groth Ludvigsen, Michael Ejstrup Hansen, Erik Beyerholm, Ramin Nateghi Elahi, Niels Pryds Rolsted, Jens Holme